Pharma leaders urge Europe to halt 'slow agony' of decline
Europe's top pharma firms have called on governments to take action to change the region's story from one of decay to one of "renewal and resilience."
Newsletters and Deep Dive digital magazine
Europe's top pharma firms have called on governments to take action to change the region's story from one of decay to one of "renewal and resilience."
CSL Seqirus' recently approved trivalent, cell-based influenza vaccine Aujemflu will be part of the UK's 2027/28 immunisation campaign.
Public Citizen says claims for the drug price savings that are being delivered by Trump's Most-Favoured Nation deals with pharma are "a mirage."
The complex drug pricing ecosystem means all stakeholders are scrambling to understand how the new regulations and PBMs’ adjustments will impact them.
AstraZeneca's generalised myasthenia gravis (gMG) therapy Klygefa gets CHMP recommendation, alongside several other novel medicines.
Editor's Picks
Newsletters and Deep Dive
digital magazine